2m 2m 2m 2m 2m 2m 2m
AYTU BIOPHARMA (AYTU)
NASDAQ
$2.24-$0.010 (-0.44%)
Price as of Jun 23, 2026 4:10 PM EDT- $24.1MMarket Cap
- 13.64%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AYTU BIOPHARMA (AYTU)
$2.24-$0.010 (-0.44%)
AYTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.25 | ||
Change | -$0.06 (-2.60%) | ||
Open | $2.30 | ||
High | $2.30 | ||
Low | $2.21 | ||
Previous Close | $2.25 | ||
Volume | 16,495 | ||
30-Day Average Volume | 32,547 | ||
1-Week Change | 2.27% | ||
1-Month Change | 2.74% | ||
1-Year Change | 13.64% | ||
3-Year Change | 33.93% | ||
5-Year Change | -97.99% | ||
Fundamentals | |||
Shares Outstanding | 10.7M | ||
Total Assets | $111.7M | ||
Market Cap | $24.1M | ||
Enterprise Value | $19.3M | ||
Period: QTR TTM FY | |||
Revenue | $12.4M | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$4.2M | ||
EBIT | -$5.5M | ||
EBITDA | -$4.4M | ||
Net Working Capital | $7.4M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 01/06/2023 | ||
Earnings & Revenue